Details for Belgium Supplementary Protection Certificate: 2021C/556
Belgium Supplementary Protection Certificate: 2021C/556
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2081595 | 2021C/556 | Belgium | PRODUCT NAME: DARATUMUMAB, POMALIDOMIDE EN DEXAMETHASON; AUTHORISATION NUMBER AND DATE: EU/1/16/1101 - C(2021)14720 20210623 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
